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Nephrin and podocin dissociate at the onset of proteinuria in
experimental membranous nephropathy.
Background. The slit diaphragm plays a critical role in
maintaining the barrier function of the glomerular capillary
wall. The pathogenic mechanism of proteinuria in membranous
nephropathy remains uncertain. This study was undertaken to
analyze the pathogenic role of slit diaphragm in proteinuria in
experimental membranous nephropathy.
Methods. The expression and the localization of slit
diaphragm–associated molecules (nephrin, podocin, and
CD2AP) and other podocyte-associated molecules (podoca-
lyxin and a 3 integrin) in passive and active Heymann nephritis
were analyzed by immunofluorescence and Western blot analy-
sis. The interaction of slit diaphragm–associated molecules was
investigated by the dual-labeling immunofluorescence method.
The mRNA expression of these molecules was also analyzed.
Results. Shifts in nephrin and podocin staining patterns, from
linear to granular, were detected in the early stages of pas-
sive Heymann nephritis. These shifts were not parallel, and
the dissociation of these molecules was detected by the dual-
labeling immunofluorescence method in passive and active
Heymann nephritis. Western blot analyses with sequentially
solubilized materials indicated that the nephrin-rich fraction
changed from being partly detergent-resistant to being pre-
dominantly detergent-soluble. This change did not occur with
podocin. Nephrin excreted into urine was already detected
in the early stages of passive Heymann nephritis. Decreased
mRNA expression of nephrin and podocin was observed be-
fore the onset of proteinuria. By contrast, no extensive change
in the expression of a 3 integrin was observed in this study.
Conclusion. Nephrin is dissociated from podocin and ex-
creted into urine in the early stages of Heymann nephritis. The
reduced expression of nephrin and podocin, along with their
dissociation, may contribute to the development of proteinuria
in Heymann nephritis.
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Membranous nephropathy is characterized by subep-
ithelial immune deposits and effacement of the podocyte
foot processes. The primary clinical manifestation is pro-
teinuria. Although podocyte injury and proteinuria are
mediated in membranous nephropathy by the membrane
attack complex of complement [1], the pathogenic mech-
anism of proteinuria in membranous nephropathy has not
been clarified yet. Nephrin is identified as a product of
NPHS1 [2], and is considered to be a critical component
of the epithelial slit diaphragm, maintaining the barrier
function of the glomerular capillary wall [3]. Recently,
some investigators reported that nephrin expression is
decreased at the mRNA level and/or the protein level
in membranous nephropathy [4–6]. However, another
report showed that the expression of nephrin mRNA
and protein was unchanged in patients with membra-
nous nephropathy [7]. These discrepancies might stem
from the differences in the quantitative methods used
for analysis. It is also conceivable that the difference in
the phase of the disease at which the materials were ob-
tained may result in these contradictory results. Although
an investigation of the kinetics of nephrin expression is
necessary to clarify the etiologic significance of its de-
creased expression for the development of proteinuria in
membranous nephropathy, there are restrictions on ana-
lyzing human biopsy material. Heymann nephritis in rats
is widely used as an experimental model of idiopathic
membranous nephropathy [8]. Heymann nephritis can
be modeled in two major ways: the active type, induced
by direct immunization with a rat kidney suspension of
fraction 1A (Fx1A) of kidney lysate [9], and the passive
type, induced by a passive injection of anti-Fx1A anti-
body produced in other animal species, such as rabbits
or sheep [10, 11]. Although it has been pointed out that
some pathogenic mechanisms differ between these two
types of model [12], both are accepted as models of hu-
man idiopathic membranous nephropathy. Recently, our
group reported that nephrin expression decreased in the
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early stages of passive Heymann nephritis [13, 14], which
suggests that the decreased expression of nephrin was in-
volved in the development of proteinuria in membranous
nephropathy. In the previous report, our group showed
that nephrin dissociated from actin in this disease. These
observations suggest that the dissociation of nephrin from
actin may underlie the loss of the podocyte barrier func-
tion in membranous nephropathy [13]. However, what
disrupts the nephrin-actin interaction and how nephrin-
actin dissociation results in podocyte dysfunction remains
unresolved.
Following nephrin, several other slit diaphragm–
associated molecules, such as podocin, CD2AP and
NEPH1, were identified [15–18]. Although the expres-
sion of nephrin and CD2AP has been reported in
passive Heymann nephritis [13], no studies on the
expression of podocin in membranous nephropathy
have been reported. In active Heymann nephritis, slit
diaphragm–associated molecules have not yet been an-
alyzed. Recently, the interaction of nephrin with other
slit diaphragm–associated molecules was analyzed by
pull-down assay, using cultured cells expressing these
molecules [19–22]. These studies showed that cytoplas-
mic segments of nephrin bind to the C-terminal site of
podocin [19, 20] and CD2AP [23, 24]. However, the na-
ture of the interactions in vivo between slit diaphragm–
associated molecules has remained uncertain, despite
some reported studies on their expression [25–27].
In this study, the expressions of nephrin, podocin, and
CD2AP in both passive and active Heymann nephritis
were analyzed, as well as urinary nephrin and podocin ex-
cretion in passive Heymann nephritis. Then, the interac-
tion between these slit diaphragm–associated molecules
in the models was examined. Immunohistochemical and
polymerase chain reaction (PCR) studies clearly showed
that not only nephrin but also podocin expression de-
creases during the early stages of the disease, prior to the
observation of proteinuria. We detected urinary nephrin
on day 7 of passive Heymann nephritis, when abnor-
mal proteinuria had not yet been detected. Dual-labeling
immunohistochemistry and Western blot analysis with
sequentially solubilized materials of glomerular lysate
showed that nephrin dissociates from podocin in the pro-
teinuric state. These findings suggest that the alteration
in slit diaphragm component interaction, as well as the
decrease in their expression, may be the mechanism of
proteinuria in membranous nephropathy.
METHODS
Animals
Specific pathogen-free female Wistar, male Sprague-
Dawley, and male Lewis rats were purchased from
Charles River Japan (Atsugi, Japan). All animal exper-
iments conformed to the National Institute of Health
Guide for the Care and Use of Laboratory Animals.
Preparation of Fx1A and anti-Fx1A antibodies
Fx1A was prepared in accordance with the method of
Edgington, Glassock, and Dixon [9], Edginton et al [28],
and de Heer, Daha, and van Es [29], with minor modifica-
tions. The rabbits were immunized with Fx1A four times,
and bled 2 weeks after the last immunization. The serum
obtained was incubated for 30 minutes at 56◦C, so that
the complements could be inactivated and adsorbed into
the rat red blood cells. Sheep anti-Fx1A was prepared as
described in another report [30].
Experimental protocol
Experiment 1: Studies on passive Heymann nephritis
induced by rabbit anti-Fx1A antibody (passive Heymann
nephritis rabbit). Passive Heymann nephritis was in-
duced in 16 female Wistar rats by a single intravenous
injection of 2 mL of rabbit anti-Fx1A (passive Heymann
nephritis rabbit). Five rats each were sacrificed on days
1 and 7, and three rats each on days 14 and 42. As a
control group, five age-matched normal rats were sacri-
ficed. Half of their left kidneys was cut into portions and
used for light microscopy, electron microscopy, and im-
munofluorescence. The deposition of injected rabbit IgG,
rat IgG, and rat C3 was analyzed with fluorescein isothio-
cyanate (FITC)-conjugated antirabbit immunoglobulins
(Dako, Glostrup, Denmark), FITC-conjugated antirat
immunoglobulins (Dako) and FITC-conjugated antirat
C3 (Cappel, Aurora, OH, USA), respectively. The ex-
pression of nephrin, podocalyxin, and a3 integrin was in-
vestigated by immunofluorescence staining with murine
monoclonal antinephrin antibody 5-1-6 [31–33], murine
monoclonal antipodocalyxin antibody donated by Dr. M.
Hara (Yoshida Hospital, Niigata, Japan) [34], and murine
monoclonal antibody against a3 integrin purchased from
Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA).
The a3 subunit of integrin binds only to the b 1 subunit
of integrin, although the b 1 subunit binds to various sub-
units of integrin. Therefore, in this study, we used the
anti-a3 subunit of integrin to detect the a3b 1 integrin,
which is reported to connect the basal surface of the
podocyte to the glomerular basement membrane [35–37].
In order to evaluate the staining patterns of nephrin, we
scored them in accordance with the method described by
Macconi et al [38]. A score was assigned to each individ-
ual glomerulus in the tissue section. The scores 0, 0.5, and
1.0 were used, respectively, for continuous distribution
along the glomerular capillary wall, heterogeneous dis-
tribution along the glomerular membrane (with variable
staining intensity from one region to another within the
same glomerulus), and markedly discontinuous distribu-
tion. The final score per section was then calculated as
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the weighted mean: score = (N1 × 0 + N2 × 0.5 + N3 ×
1)/(N1 + N2 + N3), where Ni (i = 1 to 3) is the number
of glomeruli in each category. The scores were assigned
blindly. On average, more than 80 glomeruli per section
were evaluated.
Twenty-four–hour urine samples were collected just
before (day 0) and on days 3, 5, 7, 11, 14, 21, 28, 35, and
42 after anti-Fx1A antibody injection. The amount of
urinary protein excretion was measured by the Bradford
method (Bio-Rad, Oakland, CA, USA). Urine samples
from rats on days 0 and 7 of passive Heymann nepritis
rabbit were used for Western blot analysis. Fifteen
microliters of urine per lane were subjected to sodium
dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) with 7.5% or 10% acrylamide gel, in accor-
dance with the method of Laemmli [39], and transferred
to polyvinylidine difluoride (PVDF) membrane strips.
These strips were then exposed to rabbit antirat nephrin
antibody [32] or rabbit antirat podocin N-terminus
antibody [40] and incubated with alkaline phosphatase–
conjugated antirabbit immunoglobulins (Bio Source
International, Tago Immunologicals, Camarillo, CA,
USA). The reaction was developed with an alkaline
phosphatase chromogen kit (5-bromo-4-chloro-3-indolil
phosphate p-toluidine salt/nitro blue tetrazolium)
(Biomedica, Foster City, CA, USA).
Glomerular RNA was prepared from the remaining
kidney tissues pooled from five rats at each time point.
Glomerular mRNA expressions of nephrin, podocin, and
CD2AP in the early phase (days 0, 1, and 7) were analyzed
by the real-time reverse transcription (RT)-PCR method.
Experiment 2: Studies on passive Heymann nephri-
tis induced by sheep anti-Fx1A antibody (passive Hey-
mann nephritis sheep). Passive Heymann nephritis was
induced in three male Sprague-Dawley rats by two in-
travenous injections of sheep anti-Fx1A, 0.25 mL and
0.5 mL, on successive days (passive Heymann nephritis
sheep). Some antibodies used for detecting the slit di-
aphragm components are rabbit antibodies and are not
available in passive Heymann nephritis rabbit, so we pre-
pared passive Heymann nephritis sheep. The rats were
sacrificed on day 7 after the first injection. As a control
group, three age-matched normal rats were sacrificed.
Twenty-four–hour urine samples were collected just be-
fore injection (day 0), on day 4, and just before sacrifice.
Small pieces of their kidney tissues were snap-frozen and
used for immunofluorescence. The stainings of nephrin,
podocin, CD2AP, podocalyxin, and a3 integrin were in-
vestigated. Two antibodies each for nephrin, podocin,
and CD2AP were prepared. For nephrin, murine mon-
oclonal ant-nephrin antibody 5-1-6 (which recognizes
the extracellular site of nephrin) [31–33] and rabbit an-
tinephrin antibody (which recognizes the intracellular
site of nephrin) [32] were used. For podocin, antibody
against the N-terminus of podocin was prepared as pre-
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Fig. 1. Western blot analysis of the solubilized glomerular proteins
with antipodocin and anti-CD2AP antibodies. Normal rat glomeruli
were solubilized with sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE) sample buffer. The solubilized glomeruli
were loaded onto a 10% polyacrylamide gel, electrophoresed, and
transferred to a polyvinylidine difluoride (PVDF) membrane. The
stripes were stained with alkaline phosphatase–conjugated antirabbit
immunoglobulins after exposure with anti-CD2AP antibody (NI21-
25) (lane 1), antipodocin antibody against the N-terminus of podocin
(lane 2), antipodocin antibody against the C-terminus of podocin
(lane 3), or preimmune rabbit serum (lane 4). Bands of approximately
80 kD were detected by anti-CD2AP antibody (NI21-25) (lane 1). A
band of approximately 42 kD was detected by antipodocin antibodies
(lanes 2 and 3). No bands were detected by the preimmune rabbit serum
(lane 4).
viously described [40]. Antibody against the C-terminus
of podocin was prepared in rabbits immunized with a pep-
tide of 17 amino acids from the human podocin sequence
SKPVEPLNPKRKDSPML. For CD2AP, anti-CD2AP
antibody (NI21-25) was prepared in rabbits immunized
with whole molecules of CD2AP (fusion protein), and
another rabbit anti-CD2AP antibody (SC9137) was pur-
chased from Santa Cruz Biotechnology, Inc. This anti-
body recognizes the C-terminal end of CD2AP which
binds to nephrin [23, 24]. The specificities of the anti-
body against the C-terminus of podocin and the anti-
CD2AP antibody (NI21-25) were confirmed by Western
blot analysis. The Western blot findings are shown in
Figure 1. The staining patterns of nephrin, podocin,
CD2AP, and a3 integrin were evaluated in accordance
with the method described in Experiment 1. The stain-
ing pattern of podocalyxin could not be evaluated by
this method, because under careful observation it was
found to be discontinuous even in normal glomeruli. In
order to compare the localization of nephrin with that of
podocin or CD2AP, dual-labeling immunofluorescence
studies were carried out. In order to analyze the subcel-
lular localization of nephrin and podocin, semiquantita-
tive Western blot analysis with sequentially solubilized
glomerular samples was carried out.
Experiment 3: Studies on active Heymann nephritis.
Active Heymann nephritis was induced in nine male
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Lewis rats by five immunizations with Fx1A, and four
rats showing massive proteinuria were sacrificed 19 weeks
after the first immunization. As a control group, three
age-matched normal rats were sacrificed. Twenty-four–
hour urine samples were collected every week after the
first immunization. Kidney sections were used for the
immunofluorescence study. The depositions of rat IgG
and rat C3 were analyzed in accordance with the method
described in Experiment 1. The stainings of nephrin,
podocin, CD2AP, podocalyxin, and a3 integrin were in-
vestigated with the antibodies described above. The stain-
ing patterns of nephrin, podocin, CD2AP, and a3 integrin
were scored by the same method as in Experiment 1.
In order to compare the localization of nephrin with
that of podocin or CD2AP, dual-labeling immunofluores-
cence studies were carried out. For the dual-labeling im-
munofluorescence studies, rabbit anti-CD2AP antibody
(SC9137) was used.
Morphologic and immunohistochemical studies
Light and electron microscopic studies were performed
according to the previously described methods [31, 32,
34]. For light microscopy, a section was stained with pe-
riodic acid-methenamine silver.
Immunofluorescence studies were performed accord-
ing to the method previously described [41]. Renal
tissue was quickly frozen in n-hexane cooled at −70◦C.
Three micrometer thick cryostat sections were fixed,
incubated with the primary antibodies described above,
and stained with FITC-conjugated antimouse IgG1
(Southern Biotechnology Associates, Inc., Birmingham,
AL, USA) (for antinephrin monoclonal antibody 5-1-6,
anti-a3 integrin), FITC-conjugated antimouse IgG2a
(Southern Biotechnology Associates) (for antipodoca-
lyxin), or FITC-conjugated antirabbit immunoglob-
ulins (Dako) (for antinephrin, antipodocin, and
anti-CD2AP). For dual-labeling immunofluores-
cence analysis, tetramethyl rhodamine isothiocyanate
(TRITC)-conjugated anti-mouse IgG1 (Southern
Biotechnology Associates) was used to detect an-
tinephrin monoclonal antibody 5-1-6. The species were
observed with an immunofluorescence microscopy
(BX50) (Olympus, Tokyo, Japan), or with a laser-
scanning confocal microscopy (MRC-1024) (Bio-Rad)
with the appropriate filter for FITC (488 nm excitation,
HQ515/30 emission filter) and TRITC (568 nm exci-
tation, 585LP filter). X-y and x-z scans were obtained.
Images were further processed using Adobe Photoshop
6.0.
Semiquantitative Western blot analysis with sequentially
solubilized glomerular lysates
Western blot analysis with sequentially solubilized
glomerular lysates was performed basically according to
the method previously described [40]. Glomeruli from
rats of passive Heymann nephritis sheep (days 0 and
7) were isolated with phosphate-buffered saline (PBS),
including protease inhibitors. Ten thousand glomeruli
of each sample were sequentially solubilized with 1%
Triton X-100, RIPA buffer [0.1% SDS, 1% sodium de-
oxycholate, 1% Triton X-100, 0.15 mol/L NaCl, and
0.01 mol/L ethylenediaminetetraacetic acid (EDTA)
in 0.025 mol/L Tris-HCl, pH 7.2] with protease in-
hibitors, and then separated into Triton X-100-soluble
(T), RIPA-soluble (R), and RIPA-insoluble fractions.
The RIPA-insoluble fraction was solubilized with SDS-
PAGE sample buffer (2% SDS, 10% glycerol, and 5%
2-mercaproethanol in 0.0625 mol/L Tris-HCl, pH 6.8)
(S fraction). Equal amounts of these sequentially solubi-
lized fractions were subjected to SDS-PAGE with 7.5% or
10% acrylamide gel, according to the method of Laemmli
[39] and transferred to a PVDF membrane (Bio-Rad) by
electrophoretic transblotting for 30 minutes using Trans-
Blot SD (Bio-Rad). After blocking with bovine serum
albumin (BSA), the strips of membrane were exposed to
rabbit antirat nephrin [32], rabbit antirat podocin [40],
or rabbit antirat actin antibody purchased from Sigma-
Aldrich (St. Louis, MO, USA). They were then washed
and incubated with alkaline phosphatase–conjugated an-
tirabbit immunoglobulins. The reaction was developed
with an alkaline phosphatase chromogen kit. The density
of the positive bands was quantitated by Densitograph
(ATTO, Tokyo, Japan). This procedure was carried out
twice. The percentage of the density of each fraction to the
total was calculated. The percentage of the total amount
of each molecule in passive Heymann nephritis sheep
compared to the control group is shown in bar graphs as
mean ± SD.
Real-time RT-PCR
Total RNA was extracted from isolated glomeruli by
Trizol (Gibco BRL, Gaithersburg, MD, USA). cDNA
was synthesized according to the method previously de-
scribed [32, 40]. The primers of nephrin, podocin, and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
were designed according to the published sequence [32,
40]. The primers of CD2AP were designed based on
its sequence (GenBank AY205155) (CD2AP) (sense
5′-GAG GTA GAA GAA GGC TGG TGG AGT
G-3′ and antisense 5′-CAG CCT GCT TCT CCA GTC
TCC TT-3′). Real-time RT-PCR was performed with
Takara Ex Taq R-PCR Version 1.0 (Takara, Otsu, Japan)
and SYBR Green I (Takara), in accordance with the
manufacturer’s instructions. The template cDNA were
amplified in a 25 lL total volume of PCR buffer con-
taining 2.5 lL of 10 × R-PCR buffer (Mg2+ free),
0.00084 lL of SYBR Green I, 3 mmol/L MgCl2, 0.3
mmol/L each deoxyadenosine triphosphate (dATP),
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Fig. 2. Morphologic studies on passive Hey-
mann nephritis induced by rabbit antifrac-
tion 1A (anti-Fx1A). The light microscopic
findings [periodic acid-methenamine silver
(PAM) stain] for passive Heymann nephri-
tis rabbit are shown in the upper panel. The
spike formation characteristic of Heymann
nephritis was not observed in the control rats
(passive Heymann nephritis rabbit, day 0).
No spike formation was observed on day 7,
either. However, spike formations along the
glomerular capillary wall (arrows) were ob-
served on day 14 (×1000). The electron micro-
scopic findings for passive Heymann nephritis
rabbit are shown in the lower panel. A slit di-
aphragm was observed in the control rats (day
0). A partial effacement of the podocyte foot
processes (arrow heads) was observed on day
7. Subepithelial deposits (∗) and effacement
of the podocyte foot processes were observed
on day 14.
deoxycytidimine triphosphate (dCTP), deoxyguanosine
triphosphate (dGTP), and deoxythymidine triphosphate
(dTTP), and 0.3 lmol/L of each of the 5′ and 3′ primers
and 1.25 U of Takara Ex Taq HS. Two-step PCRs were run
on a Smart Cycler System I (Takara) of denaturation at
95◦C for 3 seconds, annealing at individual temperatures
for 30 seconds. The reactions and runs were performed six
times for each sample. PCR products of nephrin, podocin,
CD2AP, and GAPDH were subcloned into the plasmid
vector pCR II-TOPO (TOPO TA Cloning Kit Dual Pro-
moter) (Invitrogen, Carlsbad, CA, USA). The plasmid
DNAs subcloned with the PCR products were isolated
and purified with a Plasmid Midi Kit (Qiagen, Hilden,
Germany). The concentration of each plasmid was deter-
mined by measurements of the absorbance at 260 nm, and
its copy number was calculated. In order to generate the
calibration curves, the stock solutions were diluted from
104 to 109 copies/lL. The fluorescence intensity of 400
nmol/L FAM (carboxyfluorescein) was defined as 1000
U, and the threshold was set at 30 U of fluorescence in-
tensity. The Ct value was defined as the cycle number at
which the fluorescence intensity curve crosses this thresh-
old. The calibration curve was plotted as Ct (x axis) versus
the logarithm of the starting copy number (y axis).
RESULTS
Experiment 1: Passive Heymann nephritis rabbit
Characterization of passive Heymann nephritis rabbit.
The amounts of urinary protein excretion on days 0, 7,
14, and 42 in passive Heymann nephritis rabbit were
3.5 ± 0.4, 5.3 ± 0.9, 238.5 ± 93.8, and 41.0 ± 14.3 mg/day,
respectively. The deposition of rabbit IgG and rat C3 in
the glomeruli was detected on day 1. The deposition of rat
IgG was first detected on day 14 (data not shown). The
light and electron microscopic findings in passive Hey-
mann nephritis rabbit are shown in Figure 2. No extensive
morphologic alteration was observed on day 7 in passive
Heymann nephritis rabbit, although a partial effacement
of the podocyte foot processes was observed. Spike for-
mations along the glomerular capillary wall were first de-
tected on day 14. Subepithelial deposits and effacement
of the podocyte foot processes were well noticeable on
day 14.
Immunoﬂuorescence stainings of podocyte-associated
molecules in passive Heymann nephritis rabbit. The ki-
netics of the immunofluorescence stainings of nephrin
detected by the murine antinephrin monoclonal antibody
(5-1-6) in passive Heymann nephritis rabbit are shown in
Figure 3. Nephrin staining was observed to have a linear
pattern on day 0 and day 1 (Fig. 3A and B). Discontinu-
ous staining of nephrin was observed in some glomeruli
on day 7 (Fig. 3C), and in almost all the glomeruli on day
14 and day 42 (Fig. 3D and E). By contrast, no extensive
alteration of the staining of a3 integrin or podocalyxin
was detected throughout the period examined (data not
shown). The score for nephrin staining is summarized in
Figure 3F.
Analysis of urinary nephrin and podocin in passive
Heymann nephritis rabbit. The Western blot findings for
nephrin in the urine samples are shown in Figure 4 (upper
panel). Nephrin was detected as two bands of around 180
kD in glomerular lysate. A band of approximately 180 kD
corresponding to the lower band of nephrin in glomerular
lysate and other bands of around 200 kD were detected
in urine samples from rats on day 7 of passive Heymann
nephritis rabbit (lane 1). These bands were not detected
in urine samples from normal rats (lane 3) or negative
controls incubated with preimmune rabbit serum (lane
4). The Western blot findings for podocin are shown in
Figure 4 (lower panel). Urinary podocin was detected
neither on day 0, nor on day 7.
mRNA expression of slit diaphragm–associated
molecules in passive Heymann nephritis-rabbit. The
calibration curves are GAPDH, y = −0.301x + 12.301
(r2 = 0.998); nephrin, y = −0.306x + 12.615 (r2 = 0.998);
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Fig. 3. Immunofluorescence findings for nephrin in passive Heymann
nephritis induced by rabbit antifraction 1A (anti-Fx1A). Nephrin stain-
ing with monoclonal antibody 5-1-6 was observed to have a linear pat-
tern on day 0 (A) and day 1 (B). Some glomeruli showed granular
patterns on day 7 (C), when abnormal proteinuria was not observed
yet. Most glomeruli showed granular patterns on day 14 (D) and day
42 (E). The kinetics of the nephrin staining score is shown in (F). The
staining patterns of nephrin were evaluated using the method described
in the Methods section.
podocin, y = −0.319x + 12.796 (r2 = 1.000); and CD2AP,
y = −0.283x + 11.169 (r2 = 0.999). The copy numbers
of mRNA for nephrin, podocin, and CD2AP per 108
copies of GAPDH mRNA in the early phase of passive
Heymann nephritis rabbit (days 0, 1, and 7) are shown
in Figure 5. Glomerular mRNA expressions of nephrin
decreased to 46.8% on day 1 and 24.0% on day 7.
Glomerular mRNA expressions of podocin decreased to
44.2% on day 1 and 24.1% on day 7. A slight decrease
of mRNA expression of CD2AP was detected on day 7
(67.3%).
Experiment 2: Passive Heymann nephritis sheep
Characterization of passive Heymann nephritis sheep.
The amounts of urinary protein excretion in passive Hey-
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Fig. 4. Western blot analyses of urinary nephrin and podocin in pas-
sive Heymann nephritis induced by rabbit antifraction 1A (anti-Fx1A).
Urinary nephrin was examined by Western Blot analysis in passive Hey-
mann nephritis rabbit (upper panel). Nephrin was detected as two bands
of around 180 kD in glomerular lysate (lane 2, arrows). A band of
around 180 kD corresponding to the lower band of nephrin of glomeru-
lar lysate and other bands of around 200 kD were detected in the urine
samples of rats on day 7 of passive Heymann nephritis rabbit (lane 1).
These bands were not detected in urine samples from normal rats (lane
3) or negative controls incubated with preimmune rabbit serum (lane
4). The lower panel shows the Western Blot findings for podocin in the
urine samples. A podocin band of approximately 42 kD was detected in
the glomerular lysate. Urinary podocin was not detected on day 0 (lane
3) or day 7 (lane 1). Lanes 1 and 4 show the urine of rats on day 7 of pas-
sive Heymann nephritis rabbit. Lane 2 is the glomerular lysate (positive
control). Lane 3 is the urine of control rats (day 0). Lanes 1 to 3 were
exposed to antinephrin antibody (upper panel) or antipodocin antibody
(lower panel). Lane 4 was exposed to preimmune rabbit serum.
mann nephritis caused by sheep anti-Fx1A (passive Hey-
mann nephritis sheep) on days 0, 4, and 7 were 2.1 ± 0.4,
7.5 ± 3.6, and 83.5 ± 8.8 mg/day, respectively.
Immunoﬂuorescence stainings of podocyte-associated
molecules in passive Heymann nephritis sheep. The
immunofluorescence findings of podocyte-associated
molecules on day 7 of passive Heymann nephritis sheep
are shown in Figure 6. Not only nephrin, but also podocin
and CD2AP staining shifted to a discontinuous pattern on
day 7 of passive Heymann nephritis sheep. By contrast, no
extensive alteration of the staining of podocalyxin or a3
integrin was detected from the control to the passive Hey-
mann nephritis sheep. For staining of nephrin, podocin
and CD2AP, two antibodies against each molecule were
used. For each molecule, no difference in staining was
detected between the two antibodies. The scores for the
distribution of podocyte-associated molecules in passive
Heymann nephritis sheep are shown in Figure 6 (lower
panel).
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Fig. 5. Real-time reverse transcription-polymerase chain reaction (RT-
PCR) analysis of slit diaphragm–associated molecules in the glomeruli
of passive Heymann nephritis induced by rabbit antifraction 1A (anti-
Fx1A). The left panel shows the fluorescence intensity of the RT-PCR
analyses of nephrin, podocin, CD2AP, and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH). The x axis shows the number of PCR cycles,
and the y-axis shows the fluorescence intensity. The lines in the graphs
The dual-labeling results for nephrin with podocin and
CD2AP in passive Heymann nephritis sheep are shown
in Figure 7. A merged image of nephrin with podocin
shows a yellow pattern in control rats (Fig. 7B). The stain-
ings patterns of podocin and nephrin shifted to granu-
lar in passive Heymann nephritis sheep, but the shifts of
these proteins were not parallel (Fig. 7E). Confocal mi-
croscopic studies also showed podocin and nephrin were
dissociated in passive Heymann nephritis sheep (day 7)
(Fig. 7N). The staining patterns of CD2AP and nephrin
were linear in the control rats. Although the staining pat-
terns of CD2AP and nephrin were not completely coinci-
dent, they were very similar in the control rats (Fig. 7H).
In the glomeruli of rats with passive Heymann nephri-
tis sheep, nephrin and CD2AP were redistributed, and
some portions of the nephrin staining were clearly diver-
gent from those of CD2AP (Fig. 7K).
Semiquantitative Western blot analysis with sequen-
tially solubilized glomerular lysates. The amounts of
nephrin and podocin and their subcellular localization
were analyzed by Western blot analysis with sequen-
tially solubilized glomerular lysates in passive Heymann
nephritis sheep (Fig. 8). Nephrin was detected as two
bands in some fractions. However, the intensities of two
bands were quantified together, because the lower band
was very weak. The total amount of nephrin and podocin
clearly decreased (52.9 ± 12.4% and 62.7 ± 17.7% to
normal, respectively), although the amount of actin did
not change (represented as bar graphs). The ratio of the
amount of nephrin in the Triton X-100 soluble fraction
to the total amount of nephrin increased in the protein-
uric state (passive Heymann nephritis sheep 59.7% ver-
sus control 39.7%), although the distribution of podocin
in the fractions remained unchanged (passive Heymann
nephritis sheep 28.8% versus control 28.4%).
Experiment 3: Active Heymann nephritis
Characterization of active Heymann nephritis. On
week 19 of active Heymann nephritis, spike formations
along the glomerular capillary wall were observed by light
microscopy, and subepithelial deposits were observed
by electron microscopy (data not shown). Deposition
of rat IgG and C3 was observed in the glomeruli of ac-
tive Heymann nephritis rats (data not shown). Abnormal
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
are: a, passive Heymann nephritis day 0; b, passive Heymann nephritis
day 1; and c, passive Heymann nephritis day 7. Dot-dash lines indicate
the threshold that was set at 30 U of fluorescence intensity. The right
panel shows the copy numbers of mRNA for nephrin, podocin and
CD2AP per 108 copies of GAPDH mRNA. The copy numbers were
determined using the calibration curves. The PCR reactions and runs
were performed six times per each sample. The columns represent mean
values of six examinations, and the bars show 1 standard deviation.
Glomerular mRNA levels of nephrin and podocin were clearly reduced
on day 7 of passive Heymann nephritis rabbit.
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Control PHN proteinuria was first detected 10 weeks after the first im-
munization in four out of nine rats (57.0 ± 23.8 mg/24
hours). These rats had massive proteinuria (516 ± 411
mg/24 hours) at the time of their death (19 weeks after
the first immunization).
Immunoﬂuorescence stainings of podocyte-associated
molecules in active Heymann nephritis. The immunoflu-
orescence findings for the slit diaphragm–associated
molecules nephrin, podocin, and CD2AP, and the other
podocyte-associated molecules podocalyxin and a3 inte-
grin on week 19 of active Heymann nephritis are shown
in Figure 9. Shifts in the staining patterns of the slit
diaphragm–associated molecules nephrin, podocin, and
CD2AP were also observed in active Heymann nephri-
tis (Fig. 9B, D, and F). In active Heymann nephritis, the
staining intensity of podocalyxin decreased (Fig. 9H).
No differences were detected in the staining of a3 inte-
grin between the control and active Heymann nephritis
(Fig. 9J). For the staining of nephrin, podocin, and
CD2AP, two antibodies against each molecule were used.
No difference in staining was detected between the two
antibodies of each molecule. The scores for the distribu-
tion of podocyte-associated molecules in active Heymann
nephritis are shown in Figure 9 (lower panel).
The dual-labeling results of nephrin with podocin
and CD2AP in active Heymann nephritis are shown in
Figure 10. Nephrin-podocin dissociation was also ob-
served in active Heymann nephritis (Fig. 10E and N).
Although the staining patterns of CD2AP and nephrin
were very similar in control rats (Fig. 10H), some por-
tions of the nephrin staining were clearly divergent from
those of CD2AP (Fig. 10K) in the glomeruli of active
Heymann nephritis rats.
DISCUSSION
The kinetics of nephrin staining in passive Heymann
nephritis induced in rats by rabbit anti-Fx1A antibody
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
Fig. 6. Immunofluorescence findings for podocyte-associated
molecules in passive Heymann nephritis induced by sheep antifraction
1A (anti-Fx1A) (day 7). The nephrin staining with monoclonal
antibody 5-1-6 (A and B), podocin staining with rabbit antibody
against the N-terminus of podocin (C and D), CD2AP staining with
anti-CD2AP antibody (NI21-25) (E and F), podocalyxin staining with
monoclonal anti-podocalyxin antibody (G and H), and a 3 integrin
staining with monoclonal antibody against a3 integrin (I and J)
are shown. The stainings patterns of nephrin (A), podocin (C), and
CD2AP (E) were linear in control rats. The stainings patterns of
nephrin (B), podocin (D), and CD2AP (F) shifted to granular (arrow)
in rats on day 7 of passive Heymann nephritis sheep. By contrast, no
extensive differences in the stainings of podocalyxin (G and H) or a 3
integrin (I and J) were detected between the control (G and I) and
passive Heymann nephritis sheep (H and J). The lower panel shows
the staining score for nephrin, podocin, CD2AP, and a 3 integrin. The
staining patterns were scored in accordance with the method described
in the Methods section.
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Fig. 7. Dual-labeling results for podocin and CD2AP with nephrin in passive Heymann nephritis induced by sheep antifraction 1A (anti-Fx1A) (day
7). (A to F) The cryostat sections were incubated with rabbit antirat podocin antibody against the N-terminus of podocin, fluorescein isothiocyanate
(FITC)-conjugated antirabbit immunoglobulins, antirat nephrin monoclonal antibody 5-1-6, and TRITC-conjugated antimouse IgG1, in that order.
The localizations of podocin [green staining (A and D)] and nephrin [red staining (C and F)], and the double-exposure findings (B and E) are
shown. The stainings patterns of podocin (A) and nephrin (C) were linear in control rats. A merged image of podocin and nephrin (B) shows yellow
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Fig. 8. Western blot analyses of the sequen-
tially solubilized glomerular proteins with
antinephrin and antipodocin antibodies in
passive Heymann nephritis induced by sheep
antifraction 1A (anti-Fx1A) (day 7). The
amounts of nephrin and podocin and their
subcellular localization were analyzed by
Western blot analysis with sequentially solu-
bilized glomerular lysates. Isolated glomeruli
from normal and rats with passive Heymann
nephritis sheep (day 7) were sequentially
solubilized with Triton X-100, RIPA buffer,
and sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) sample
buffer. Equal amounts of these sequentially
solubilized fractions were loaded onto a
polyacrylamide gel, electrophoresed, and
then transferred to a polyvinylidine difluoride
(PVDF) membrane. The membrane was incu-
bated with rabbit antinephrin antibody, rabbit
antipodocin antibody, or rabbit antiactin
antibody, followed by alkaline phosphatase–
conjugated anti-rabbit immunoglobulins.
Abbreviations are: T, Triton X-100 soluble
fractions; R, Triton X-100-insoluble and
RIPA buffer soluble fractions; S, RIPA buffer
insoluble and SDS-PAGE sample buffer
soluble fractions. The densities of the positive
bands were quantified. The percentages of
the total amount of each molecule in rats with
passive Heymann nephritis sheep compared
to those in the control rats are shown in
the bar graphs as mean ± SD. In rats with
passive Heymann nephritis sheep on day 7,
the total amounts of nephrin and podocin
clearly decreased (52.9 ± 12.4% and 62.7
± 17.7% to the control level, respectively;
upper panel). The percentages of the amount
of each fraction to the total are shown below
the bands. The ratio of the amount of nephrin
in the Triton X-100 soluble fractions to the
total amount of nephrin increased in passive
Heymann nephritis sheep (59.7%) and
control (39.7%), although the distribution of
podocin in the fractions remained unchanged
(lower panel).
was analyzed using a murine monoclonal antinephrin
antibody (5-1-6) which recognizes the extracellular site
of rat nephrin [31–33]. The staining pattern of nephrin
was already disrupted in some glomeruli on day 7, when
neither abnormal proteinuria nor spike formation had
yet been detected. Nephrin staining clearly shifted to
a discontinuous granular pattern on day 14, when se-
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
staining in control rats. The staining patterns of podocin (D) and nephrin (F) shifted to granular in passive Heymann nephritis sheep (day 7), but the
shifts of these molecules were not parallel (merged image) (E). Podocin and nephrin did not always colocalize in passive Heymann nephritis sheep
(arrows are green staining; arrow heads are red staining). (G to L) The sections were incubated with rabbit antirat CD2AP antibody (NI21-25),
FITC-conjugated antirabbit immunoglobulins, antirat nephrin monoclonal antibody 5-1-6, and TRITC-conjugated antimouse IgG1, in that order.
The localizations of CD2AP [green staining (G and J)] and nephrin [red staining (I and L)], and the double-exposure findings (H and K) are shown.
The staining patterns of CD2AP (G) and nephrin (I) were linear in control rats. The staining patterns of CD2AP and nephrin were very similar
(merged image) (H). The stainings of CD2AP (J) and nephrin (L) suffered redistribution in passive Heymann nephritis sheep (day 7). A merged
image of CD2AP with nephrin (K) shows that some portions of the nephrin staining clearly diverge from the CD2AP staining in passive Heymann
nephritis sheep (arrows are green staining; arrow heads are red staining). (M and N) Confocal microscopic findings of the merged image of podocin
and nephrin. The dual-label staining was done as described (A to F). The localizations of podocin (green staining) and nephrin (red staining) in
the horizontal sections (upper panel) and in the vertical sections (lower panel) are shown. Nephrin and podocin colocalized in control rats (M). In
passive Heymann nephritis sheep, podocin (green staining) and nephrin (red staining) are clearly dissociated (N).
vere proteinuria was observed (Fig. 3). These findings
are compatible with previous reports [13, 14, 42]. We
also analyzed the staining of podocin and CD2AP as well
as nephrin in passive Heymann nephritis rabbit. Since
some antibodies used for detecting these slit diaphragm–
associated molecules are rabbit antibodies and are
not available in passive Heymann nephritis rabbit, we
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Control AHN prepared passive Heymann nephritis sheep. We observed
that the staining patterns of all of these slit diaphragm–
associated molecules shifted to discontinuous in the pro-
teinuric stage of this passive Heymann nephritis model
(Fig. 6B, D, and F). In this study, we found that the stain-
ing pattern of CD2AP was altered in passive Heymann
nephritis sheep, although our group previously reported
that the staining intensity of CD2AP did not diminish
[13]. No extensive alteration of podocalyxin or a3 inte-
grin was detected in passive Heymann nephritis rabbit
(data not shown) or in passive Heymann nephritis sheep
(Fig. 6). a3b 1 integrin plays a major role in connecting the
basal side of podocyte to the glomerular basement mem-
brane [35–37]. Podocalyxin is a podocyte apical mem-
brane molecule with a negative charge [43]. It is believed
that podocalyxin plays a role in maintaining the highly
differentiated structure of the podocyte, with its inter-
digitating foot processes [44, 45]. The findings obtained
here may indicate that alterations in the expression of slit
diaphragm–associated molecules which are essential for
the development of proteinuria, rather than the alteration
of the apical and basal molecules of the podocyte. The
stainings of nephrin, podocin, and CD2AP were analyzed
with the help of two antibodies against each molecule,
and no differences in the findings between the two an-
tibodies for each molecule were detected. This strongly
suggests that the shifts in the staining patterns are due not
to the alteration of a portion of these molecules, but to
the alteration of the whole molecule. In order to further
analyze the etiological significance of the alteration of slit
diaphragm components, we analyzed the mRNA expres-
sion of slit diaphragm–associated molecules (nephrin,
podocin, and CD2AP) at the early stages of this model
(Fig. 5). We found that the mRNA expression of nephrin
and podocin decreased prior to the onset of proteinuria.
These findings show that there is decreased synthesis
of slit diaphragm components, which likely contributes
to the reduction in slit diaphragm protein levels. These
changes may initiate the onset of proteinuria. All of these
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
Fig. 9. Immunofluorescence findings for podocyte-associated
molecules in active Heymann nephritis. The nephrin staining with
monoclonal antibody 5-1-6 (A and B), podocin staining with rabbit
antibody against the N-terminus of podocin (C and D), CD2AP
staining with anti-CD2AP antibody (NI21-25) (E and F), podocalyxin
staining with monoclonal antipodocalyxin antibody (G and H), and
a3 integrin staining with monoclonal antibody against a3 integrin (I
and J) are shown. The staining patterns of nephrin (A), podocin (C),
and CD2AP (E) were linear in control rats. The staining patterns of
nephrin (B), podocin (D) and CD2AP (F) were granular (arrow) in
active Heymann nephritis. (G) The staining of podocalyxin in normal
rats. The staining intensity of podocalyxin was diminished (arrows) in
active Heymann nephritis (H). No differences were detected in the
staining of a3 integrin between the control (I) and active Heymann
nephritis (J). The lower panel shows the staining scores for nephrin,
podocin, CD2AP, and a 3 integrin. The staining patterns were scored
in accordance with the method described in the Methods section.
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Fig. 10. Dual-labeling results for podocin and CD2AP with nephrin in active Heymann nephritis. (A to F) The cryostat sections were incubated
with rabbit antirat podocin antibody against the N-terminus of podocin, fluorescein isothiocyanate (FITC)-conjugated antirabbit immunoglobulins,
antirat nephrin monoclonal antibody 5-1-6, and TRITC-conjugated anti-mouse IgG1, in that order. The localizations of podocin [green staining (A
and D)] and nephrin [red staining (C and F)], and the double-exposure findings (B and E) are shown. The staining patterns of podocin (A) and
nephrin (C) were linear in control rats. A close proximity between podocin and nephrin is observed in normal rat glomeruli (merged image) (B).
Nakatsue et al: Nephrin-podocin dissociation in Heymann nephritis 2251
results indicate that the molecular rearrangement of the
slit diaphragm components is essential for the develop-
ment of proteinuria in passive Heymann nephritis.
Some recent studies have shown by pull-down assay
that nephrin interacts with podocin [19, 20] and CD2AP
[21], and other studies have shown that podocin plays
a part in the recruitment of nephrin into the slit pore
of the podocyte [22, 46]. It has also been reported that
nephrin-induced signals are enhanced by podocin [20,
46]. These studies indicate that the interaction of these slit
diaphragm–associated molecules is essential in maintain-
ing slit diaphragm function. Therefore, in order to analyze
the alteration of the interaction of nephrin with podocin
and CD2AP, we investigated the localization of nephrin,
podocin, and CD2AP with dual-labeling immunofluores-
cence techniques. A close proximity between nephrin and
podocin was observed in normal rat glomeruli, but the
localizations of these molecules were not coincident in
the glomeruli of proteinuric rats with passive Heymann
nephritis sheep (Fig. 7). Nephrin and CD2AP showed
very similar linear staining patterns along the glomeru-
lar capillary wall, although their localizations were not
completely coincident even in normal rat glomeruli. We
observed that nephrin and CD2AP were redistributed
in passive Heymann nephritis sheep, and a portion of
the nephrin staining was clearly divergent from that of
CD2AP (Fig. 7). These findings indicate that the altered
interaction of the slit diaphragm components, as well as
the decreased expression of these molecules, may con-
tribute to the development of proteinuria in this model
of membranous nephropathy.
In this study, the subcellular localizations of nephrin
and podocin in proteinuric glomeruli were also ana-
lyzed by Western blotting with sequentially solubilized
materials (Fig. 8). We previously reported that the Tri-
ton X-100 soluble fraction was rich in nephrin, and
that nephrin was also found in the Triton X-100 in-
soluble/RIPA soluble fraction and the RIPA insoluble
fraction of normal rat glomeruli. By contrast, podocin
is mainly found in the Triton X-100 insoluble/RIPA
soluble and the RIPA insoluble fractions [40]. In this
study, we analyzed whether nephrin and podocin-rich
fractions shift in the pathogenic glomeruli of rats with
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
The stainings patterns of podocin (D) and nephrin (F) shifted to granular in active Heymann nephritis, but the shifts of these molecules were not
parallel (merged image) (E). Podocin and nephrin did not always colocalize in active Heymann nephritis (arrows are green staining; arrow heads are
red staining). (G to L) The sections were incubated with rabbit antirat CD2AP antibody (SC9137), FITC-conjugated antirabbit immunoglobulins,
antirat nephrin monoclonal antibody 5-1-6, and TRITC-conjugated antimouse IgG1, in that order. The localizations of CD2AP [green staining (G
and J)] and nephrin [red staining (I and L)], and the double-exposure findings (H and K) are shown. The staining patterns of CD2AP (G) and
nephrin (I) were linear in control rats. The staining patterns of CD2AP (J) and nephrin (L) shifted to granular in active Heymann nephritis. A
merged image of CD2AP with nephrin (K) shows that some portions of the nephrin staining are clearly divergent from the CD2AP staining in
active Heymann nephritis (arrows are green staining; arrow heads are red staining). (M and N) Confocal microscopic findings of a merged image
of podocin and nephrin. The dual-label staining was done as described (A to F). The localizations of podocin (green staining) and nephrin (red
staining) in the horizontal sections (upper panel) and in the vertical sections (lower panel) are shown. Nephrin and podocin colocalized in control
rats (M). Podocin and nephrin are clearly dissociated in active Heymann nephritis (N).
passive Heymann nephritis sheep. We found that the ra-
tio of the amount of nephrin in the Triton X-100 solu-
ble fraction to that of the total amount of nephrin was
elevated in passive Heymann nephritis sheep, whereas no
such shift was detected in podocin. These results indicate
that nephrin became more soluble in the mild detergent,
while podocin did not. The detergent resistance of mem-
brane proteins is related to their association with the cy-
toskeleton and/or detergent-resistant lipid rafts. Nephrin
is associated with the cytoskeleton and resides partly in
lipid rafts [47]. It can be solubilized by disrupting F-actin,
whereas podocin is solubilized by dissolving the lipid rafts
[19]. Thus, the most plausible explanation for the relative
increase in the solubility of nephrin but not of podocin
in passive Heymann nephritis is that podocyte injury
causes nephrin to dissociate from podocin and the actin
cytoskeleton [13].
We have shown here that urinary nephrin is found
in passive Heymann nephritis rabbit (Fig. 4). Although
Patari et al [48] reported that some small fragments of
nephrin were detected in patients with diabetes, some
studies reported that nephrin bands of 180 ∼ 160 kD
were detected in the urine of proteinuric rats [49, 50].
We detected a nephrin band of around 180 kD, which
corresponds to the lower band of glomerular lysate, in
the urine of rats with passive Heymann nephritis rabbit.
It is not clear that the nephrin detected in this urine is
membrane-associated, since Simons et al [51] reported
that the upper band of nephrin is membrane-associated
and the lower band is endoplasmic reticulum–associated.
We also detected some other bands around 200 kD in
urine samples of rats with passive Heymann nephritis
rabbit. Although we cannot clearly explain the character-
istics of these bands, we think that they might be proteins
aggregated with nephrin. Our Western blot study with se-
quentially solubilized glomerular lysate showed that the
solubility of nephrin increased, whereas that of podocin
did not. Podocin was not detected in the urine samples in
which nephrin was detected. These findings suggest that
it is conceivable that the membrane-associated nephrin
was dissociated from podocin and excreted into the urine,
although we have not fully understood the character-
istics of each band of nephrin. Also, we would like to
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emphasize that urinary nephrin was detected on day 7 of
passive Heymann nephritis rabbit, when no abnormal
proteinuria was detected yet. Patari et al [48] also re-
ported that urinary nephrin was present in normoalbu-
minuric patients with type 1 diabetes. These findings sug-
gest that urinary nephrin may be of additional diagnostic
value in our understanding of podocyte injury.
Alterations in nephrin, podocin, and CD2AP stain-
ing were also detected in active Heymann nephritis. To
our knowledge, no better model than passive Heymann
nephritis and active Heymann nephritis has been de-
signed to date, although it is thought that major epitopes
causing passive Heymann nephritis do not exist in hu-
mans [52]. We believe that these experimental models are
accepted as important for the analysis of the pathogene-
sis of idiopathic membranous nephropathy. In this study,
we observed the molecular rearrangement of the slit di-
aphragm components in both active Heymann nephri-
tis and passive Heymann nephritis. The results may sug-
gest that slit diaphragm dysfunction is connected with
the development of proteinuria in human membranous
nephropathy.
CONCLUSION
In this study, we have demonstrated that alterations
in the expression and localization of slit diaphragm–
associated molecules are essential for the development
of proteinuria in experimental models of membranous
nephropathy. Immunofluorescence studies showed that
the staining patterns of nephrin, podocin, and CD2AP
already shifted from linear to granular in the early phases
of passive Heymann nephritis. Dual-labeling immunoflu-
orescence studies and Western blot analysis with sequen-
tially solubilized glomerular lysate showed that nephrin
and podocin do not colocalize in the proteinuric state
of either passive Heymann nephritis or active Heymann
nephritis. Real-time RT-PCR studies showed that the ex-
pressions of nephrin and podocin decreased prior to the
onset of proteinuria of passive Heymann nephritis rabbit.
Urinary nephrin was detected on day 7 of passive Hey-
mann nephritis rabbit when no abnormal proteinuria,
whereas podocin was not. These results indicate that the
reduced expression of nephrin and podocin, along with
their dissociation may contribute to the development of
proteinuria in membranous nephropathy.
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